Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NALIRIFOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer
NCT07020468Phase 4Active, not recruiting
- Sponsor
- Affiliated Cancer Hospital of Shantou University Medical College
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of irinotecan liposome in colon cancer, rectal cancer, sponsored by Affiliated Cancer Hospital of Shantou University Medical College. Started May 2025; status: active, not recruiting.
02
Drugs
irinotecan liposome
03
Conditions
colon cancerrectal cancer
Beyond the preview
Go deeper on NCT07020468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07020468.